HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Penghua Fang Selected Research

Type 1 Galanin Receptor

1/2018Activiated galanin receptor 2 attenuates insulin resistance in skeletal muscle of obese mice.
1/2016Central Administration of Galanin Receptor 1 Agonist Boosted Insulin Sensitivity in Adipose Cells of Diabetic Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Penghua Fang Research Topics

Disease

35Insulin Resistance
07/2022 - 06/2011
19Obesity
07/2022 - 08/2012
14Body Weight (Weight, Body)
01/2022 - 08/2011
13Type 2 Diabetes Mellitus (MODY)
01/2021 - 08/2012
11Hyperglycemia
05/2022 - 01/2016
9Glucose Intolerance
02/2022 - 10/2012
3Metabolic Diseases (Metabolic Disease)
05/2022 - 10/2021
3Pain (Aches)
12/2020 - 06/2013
3Gestational Diabetes (Gestational Diabetes Mellitus)
12/2015 - 06/2013
2Non-alcoholic Fatty Liver Disease
01/2022 - 03/2020
2Osteoporosis
01/2021 - 11/2018
2Hyperlipidemias (Hyperlipidemia)
02/2020 - 08/2012
2Dyslipidemias (Dyslipidemia)
02/2020 - 10/2012
2Alzheimer Disease (Alzheimer's Disease)
01/2017 - 09/2015
2Hyperinsulinism (Hyperinsulinemia)
01/2016 - 12/2013
2Hypertension (High Blood Pressure)
10/2012 - 08/2012
1Fatty Liver
07/2022
1Bone Resorption
11/2021
1Neuralgia (Stump Neuralgia)
12/2020
1Alcoholic Fatty Liver
02/2020
1Stomach Neoplasms (Stomach Cancer)
03/2019
1Weight Loss (Weight Reduction)
01/2019
1Psychological Trauma
01/2017
1Chronic Disease (Chronic Diseases)
01/2017
1Diarrhea
01/2016
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2016
1Wounds and Injuries (Trauma)
12/2015
1Cardiomyopathies (Cardiomyopathy)
03/2013
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2012
1Overweight
08/2012
1Coronary Artery Disease (Coronary Atherosclerosis)
08/2012

Drug/Important Bio-Agent (IBA)

31GalaninIBA
05/2022 - 06/2011
26Glucose (Dextrose)FDA LinkGeneric
05/2022 - 03/2013
10Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2018 - 06/2011
9Insulin (Novolin)FDA Link
02/2022 - 03/2013
8NeuropeptidesIBA
01/2021 - 03/2013
6baicalinIBA
01/2022 - 01/2017
6Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2014
5Peptides (Polypeptides)IBA
10/2021 - 10/2012
5Blood Glucose (Blood Sugar)IBA
03/2020 - 12/2014
4Messenger RNA (mRNA)IBA
05/2018 - 12/2014
4Galanin Receptors (Galanin Receptor)IBA
01/2017 - 03/2013
3AdiponectinIBA
07/2022 - 01/2014
3p38 Mitogen-Activated Protein KinasesIBA
01/2021 - 01/2019
3Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2014
3Hormones (Hormone)IBA
12/2015 - 06/2011
2Triglycerides (Triacylglycerol)IBA
01/2022 - 10/2021
2AdipokinesIBA
01/2022 - 01/2022
2Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 03/2020
2baicaleinIBA
02/2020 - 01/2018
2Hypoglycemic Agents (Hypoglycemics)IBA
10/2018 - 05/2014
2Type 1 Galanin ReceptorIBA
01/2018 - 01/2016
2alarinIBA
01/2015 - 12/2014
2Retinol-Binding Proteins (Retinoid Binding Proteins)IBA
12/2014 - 01/2014
1LeptinIBA
01/2022
1KisspeptinsIBA
10/2021
1Sirtuin 1IBA
01/2021
1San-HuangIBA
03/2020
1LipidsIBA
03/2020
1Pharmaceutical PreparationsIBA
03/2020
1celastrolIBA
01/2019
1Tartrate-Resistant Acid PhosphataseIBA
11/2018
1Alkaline PhosphataseIBA
11/2018
1Estrogens (Estrogen)FDA Link
11/2018
1OsteocalcinIBA
11/2018
1Type 2 Galanin ReceptorIBA
01/2018
1BuffersIBA
01/2017
1MicroRNAs (MicroRNA)IBA
01/2016
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2016
1human MIRN29B1 microRNAIBA
01/2016
1Vesicle-Associated Membrane Protein 2 (VAMP2)IBA
12/2014
12- (N- (7- nitrobenz- 2- oxa- 1,3- diazol- 4- yl)amino)- 2- deoxyglucoseIBA
12/2014
1alarin 6-25CysIBA
12/2014
1Glucose Transporter Type 4IBA
12/2014
1Galanin-Like PeptideIBA
01/2014
1GhrelinIBA
01/2014
1LigandsIBA
03/2013
1CholesterolIBA
08/2012

Therapy/Procedure

1Therapeutics
08/2012